Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Eastern Cape women giving birth in wards with leaking roofs, mould, and exposed wires

According to the CGE, only four met the two-hour response target. About 60% of cases reached court.

Eastern Cape women giving birth in wards with leaking roofs, mould, and exposed wires

The Commission for Gender Equality (CGE) has warned that Eastern Cape maternity wards and rape care centres are falling short, presenting two investigations to Parliament’s portfolio committee on health. The committee chairperson, Azwihangwisi Faith Muthambi, emphasized the need to understand the implications for accountability, service delivery, and the protection of women, mothers, newborns, and survivors of gender-based violence.

The CGE inspected six hospitals, where leaking roofs, mould, poor cleaning, and exposed electrical wires posed safety risks. Maternal mortality rates remained concerning despite a high utilization of maternal health services. The second report examined 11 Thuthuzela care centres, which provided medical, legal, and psychological support to survivors.

Only four centres met the two-hour response target, and about 60% of cases reached court. Staffing issues, lack of protocols, inconsistent oversight, and resource constraints were cited as systemic problems. MPs expressed anger, demanding accountability and questioning the department's response. The CGE's recommendations were not binding, but the department plans to report on progress by the 15th.

Written by urgent.news from The Citizen's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at citizen.co.za →

More in Health & Medicine

Obamacare $500 Refund Checks Are Here. Map Shows Where Payouts Are Coming

Trump's $500 Obamacare refund checks are rolling out to 950,000 Americans in 30 states. Here's where the payments are going.

  • Trump administration distributes $500 Obamacare refunds to 950,000 Americans
  • Refunds for those who paid full cost of coverage without premium assistance
  • Program active in 30 states using federal ACA marketplace

Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates

Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the companies have entered into a global license, development, and commercialization…

  • Samsung Bioepis and Teva form strategic partnership for biosimilar development.
  • Two candidates, SB41 and SB44, confirmed to be developed.
  • Teva handles global commercialization, Samsung manages development and manufacturing.

More from Thursday 1 October →